Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Heba A. T. Aref, Salisa Westrick, Chiahung Chou, Debra Worthington & Kimberly Garza. (2022) How to inform college students about meningitis B vaccine? Comparative effectiveness of an online theory-based text and video intervention. Journal of American College Health 0:0, pages 1-10.
Read now
Read now
Federico Martinón-Torres, Muhamed-Kheir Taha, Markus Knuf, Victoria Abbing-Karahagopian, Michele Pellegrini, Rafik Bekkat-Berkani & Véronique Abitbol. (2022) Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations. Pathogens and Global Health 116:2, pages 85-98.
Read now
Read now
Sara Viksmoen Watle, Lisbeth Meyer Næss, Gro Tunheim, Dominique A. Caugant & Torbjørn Wisløff. (2021) Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine. Human Vaccines & Immunotherapeutics 17:8, pages 2777-2787.
Read now
Read now
Liping Huang, Amir Goren, Lulu K. Lee, Vicky W. Li, Amanda Dempsey & Amit Srivastava. (2020) Disparities in healthcare providers’ interpretations and implementations of ACIP’s meningococcal vaccine recommendations. Human Vaccines & Immunotherapeutics 16:4, pages 933-944.
Read now
Read now
Federico Martinón-Torres, Terry Nolan, Daniela Toneatto & Angelika Banzhoff. (2019) Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults. Human Vaccines & Immunotherapeutics 15:12, pages 2940-2951.
Read now
Read now
Justine T. Alderfer, Mary M. Moran, Amit Srivastava & Raul E. Isturiz. (2019) Meningococcal vaccination: a discussion with all adolescents, whether college-bound or not. Postgraduate Medicine 131:8, pages 551-554.
Read now
Read now
Elizabeth M. La, Sandra E. Talbird, Koren V. Kanadanian, Liping Huang, Joel Fain & Amit Srivastava. (2019) Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease. Human Vaccines & Immunotherapeutics 15:4, pages 978-986.
Read now
Read now
Irene Rivero-Calle, Peter Francis Raguindin, Jose Gómez-Rial, Carmen Rodriguez-Tenreiro & Federico Martinón-Torres. (2019) Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B. Infection and Drug Resistance 12, pages 3169-3188.
Read now
Read now
Robert Booy, Angela Gentile, Michael Nissen, Jane Whelan & Véronique Abitbol. (2019) Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies. Human Vaccines & Immunotherapeutics 15:2, pages 470-480.
Read now
Read now
Cynthia Burman, Lidia Serra, Charles Nuttens, Jessica Presa, Paul Balmer & Laura York. (2019) Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination. Human Vaccines & Immunotherapeutics 15:2, pages 459-469.
Read now
Read now
Rino Rappuoli, Mariagrazia Pizza, Vega Masignani & Kumaran Vadivelu. (2018) Meningococcal B vaccine (4CMenB): the journey from research to real world experience. Expert Review of Vaccines 17:12, pages 1111-1121.
Read now
Read now
John L. Perez, Judith Absalon, Johannes Beeslaar, Paul Balmer, Kathrin U. Jansen, Thomas R. Jones, Shannon Harris, Laura J. York, Qin Jiang, David Radley, Annaliesa S. Anderson, Graham Crowther & Joseph J. Eiden. (2018) From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine. Expert Review of Vaccines 17:6, pages 461-477.
Read now
Read now
Lara Evellyn do Macedo, Viviane Matos Ferreira, Caroline Alves Feitosa, Amélia Maria Pithon Borges Nunes, Leila Carvalho Campos & Marco Aurélio Palazzi Sáfadi. (2018) Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil. Human Vaccines & Immunotherapeutics 14:5, pages 1131-1137.
Read now
Read now
Mustapha M. Mustapha & Lee H. Harrison. (2018) Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges. Human Vaccines & Immunotherapeutics 14:5, pages 1107-1115.
Read now
Read now
Andrew Vyse, Gillian Ellsbury & Harish Madhava. (2018) Protecting UK adolescents and adults against meningococcal serogroup B disease. Expert Review of Vaccines 17:3, pages 229-237.
Read now
Read now
N. Y. Wang & A. J. Pollard. (2018) The next chapter for group B meningococcal vaccines. Critical Reviews in Microbiology 44:1, pages 95-111.
Read now
Read now
Paolo Bonanni, Giampietro Chiamenti, Giorgio Conforti, Tommasa Maio, Anna Odone, Rocco Russo, Silvestro Scotti, Carlo Signorelli & Alberto Villani. (2017) The 2016 Lifetime Immunization Schedule, approved by the Italian scientific societies: A new paradigm to promote vaccination at all ages. Human Vaccines & Immunotherapeutics 13:11, pages 2531-2537.
Read now
Read now
Elena Gianchecchi, Giulia Piccini, Alessandro Torelli, Rino Rappuoli & Emanuele Montomoli. (2017) An unwanted guest: Neisseria meningitidis – carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence. Expert Review of Anti-infective Therapy 15:7, pages 689-701.
Read now
Read now
Daniela Toneatto, Mariagrazia Pizza, Vega Masignani & Rino Rappuoli. (2017) Emerging experience with meningococcal serogroup B protein vaccines. Expert Review of Vaccines 16:5, pages 433-451.
Read now
Read now
Articles from other publishers (36)
Wilfrido Coronell-Rodriguez, Diana C. Caceres, Otavio Cintra & Adriana Guzman-Holst. (2023) Epidemiology of Invasive Meningococcal Disease in Colombia: A Retrospective Surveillance Database Analysis. Infectious Diseases and Therapy.
Crossref
Crossref
Katharina Schley, Jack C. Kowalik, Shannon M. Sullivan, Andrew Vyse, Carole Czudek, Eszter Tichy & Jamie Findlow. (2023) Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?. Vaccines 11:5, pages 940.
Crossref
Crossref
Bing Cai, Paula Peyrani, Johannes Beeslaar, Cindy Burman & Paul Balmer. (2023) Modeling persistence of hSBA titers over time following a primary series and a booster dose of MenB-FHbp. Vaccine 41:17, pages 2729-2733.
Crossref
Crossref
Samy Taha, Muhamed-Kheir Taha & Ala-Eddine Deghmane. (2022) Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France. npj Vaccines 7:1.
Crossref
Crossref
Gaëlle Pinto Cardoso, Marion Lagrée-Chastan, Marion Caseris, Joël Gaudelus, Hervé Haas, Jean-Philippe Leroy, Pierre Bakhache, Jean-François Pujol, Andreas Werner, Marie-Aliette Dommergues, Emilie Pauquet & Didier Pinquier. (2022) Overview of meningococcal epidemiology and national immunization programs in children and adolescents in 8 Western European countries. Frontiers in Pediatrics 10.
Crossref
Crossref
Milou Ohm, Susan J M Hahné, Arie van der Ende, Elisabeth A M Sanders, Guy A M Berbers, Wilhelmina L M Ruijs, Nina M van Sorge, Hester E de Melker & Mirjam J Knol. (2022) Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study. Clinical Infectious Diseases 74:12, pages 2173-2180.
Crossref
Crossref
Charles Nuttens, Jamie Findlow, Paul Balmer, David L Swerdlow & Myint Tin Tin Htar. (2022) Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017. Eurosurveillance 27:3.
Crossref
Crossref
F. Martinón-Torres, A. Banzhoff, C. Azzari, P. de Wals, R. Marlow, H. Marshall, M. Pizza, R. Rappuoli & R. Bekkat-Berkani. (2021) Recent advances in the prevention of meningococcal B disease: Real evidence from 4CMenB vaccination. Vacunas (English Edition) 22:3, pages 189-202.
Crossref
Crossref
F. Martinón-Torres, A. Banzhoff, C. Azzari, P. de Wals, R. Marlow, H. Marshall, M. Pizza, R. Rappuoli & R. Bekkat-Berkani. (2021) Avances recientes en la prevención de la enfermedad meningocócica B: evidencia real de la vacunación con 4CMenB. Vacunas 22:3, pages 189-202.
Crossref
Crossref
Federico Martinón-Torres, Angelika Banzhoff, Chiara Azzari, Philippe De Wals, Robin Marlow, Helen Marshall, Mariagrazia Pizza, Rino Rappuoli & Rafik Bekkat-Berkani. (2021) Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination. Journal of Infection 83:1, pages 17-26.
Crossref
Crossref
G. Tzanakaki, A. Xirogianni, A. Tsitsika, S.A. Clark, K. Kesanopoulos, H.B. Bratcher, A. Papandreou, C.M.C. Rodrigues, M.C.J. Maiden, R. Borrow & M. Tsolia. (2021) Estimated strain coverage of serogroup B meningococcal vaccines: A retrospective study for disease and carrier strains in Greece (2010–2017). Vaccine 39:11, pages 1621-1630.
Crossref
Crossref
Altacílio Aparecido Nunes, Ariane De Jesus Lopes De Abreu, Otavio Cintra, Monica A.C.T. Cintra, Eduardo Barbosa Coelho & Eliana Nogueira Castro De Barros. (2021) Meningococcal disease epidemiology in Brazil (2005–2018) and impact of MenC vaccination. Vaccine 39:3, pages 605-616.
Crossref
Crossref
. (2020) The Impact of Quadrivalent Meningococcal Vaccination on Disease. AAP Grand Rounds 44:6, pages 63-63.
Crossref
Crossref
Mariagrazia Pizza, Rafik Bekkat-Berkani & Rino Rappuoli. (2020) Vaccines against Meningococcal Diseases. Microorganisms 8:10, pages 1521.
Crossref
Crossref
Sarah Mbaeyi, Tracy Pondo, Amy Blain, David Yankey, Caelin Potts, Amanda Cohn, Susan Hariri, Nong Shang & Jessica R. MacNeil. (2020) Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States. JAMA Pediatrics 174:9, pages 843.
Crossref
Crossref
Chiara Azzari, Javier Diez-Domingo, Evelyn Eisenstein, Saul N. Faust, Andreas Konstantopoulos, Gary S. Marshall, Fernanda Rodrigues, Tino F. Schwarz & Catherine Weil-Olivier. (2020) Experts’ opinion for improving global adolescent vaccination rates: a call to action. European Journal of Pediatrics 179:4, pages 547-553.
Crossref
Crossref
Viviane Matos Ferreira, Ítalo Eustáquio Ferreira, How-Yi Chang, Amélia Maria Pithon Borges Nunes, Nadav Topaz, Ellen Reis Pimentel, Ana Rafaela Silva Simões Moura, Guilherme Sousa Ribeiro, Caroline Alves Feitosa, Mitermayer Galvão Reis, Xin Wang & Leila Carvalho Campos. (2020) Meningococcal carriage in young adults six years after meningococcal C conjugate (MCC) vaccine catch-up campaign in Salvador, Brazil. Vaccine 38:14, pages 2995-3002.
Crossref
Crossref
Fei He, Hong mei Yang, Guo ming Li, Bing qing Zhu, Yating Zhang, Hong lin Jiang, Min Yuan, Yongzhong Jiang & Jing Lv. (2020)
Neisseria meningitidis
carriage and risk factors among teenagers in Suizhou city in China
. Epidemiology and Infection 148.
Crossref
Crossref
Juan Carlos Sanz Moreno & Belén Ramos Blázquez. (2019) Papel del estado de portador en el control de enfermedades infecciosas y su relación con la vacunación. Revista Madrileña de Salud Pública 2:10, pages 1-8.
Crossref
Crossref
Si Si, Ella Zomer, Samantha Fletcher, Jenny Lee & Danny Liew. (2019) Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents. Vaccine 37:35, pages 5009-5015.
Crossref
Crossref
José Francisco Santos-Neto, Viviane Matos Ferreira, Caroline Alves Feitosa, Martha Silvia Martinez-Silveira & Leila Carvalho Campos. (2019) Carriage prevalence of Neisseria meningitidis in the Americas in the 21st century: a systematic review. The Brazilian Journal of Infectious Diseases 23:4, pages 254-267.
Crossref
Crossref
R. Fletcher, E. Wilkinson, P. Cleary, S. Blagden & S. Farmer. (2019) Did school characteristics affect the uptake of meningococcal quadrivalent vaccine in Greater Manchester, United Kingdom?. Public Health 171, pages 24-30.
Crossref
Crossref
Meagan E Peterson, You Li, Heather Shanks, Rebecca Mile, Harish Nair & Moe H Kyaw. (2019) Serogroup-specific meningococcal carriage by age group: a systematic review and meta-analysis. BMJ Open 9:4, pages e024343.
Crossref
Crossref
María Eugenia León, Aníbal Kawabata, Minako Nagai, Liliana Rojas, Gustavo Chamorro & Grupo del laboratorio VIMENE Paraguay. (2019)
Genotipos de
Neisseria meningitidis
aislados de pacientes con enfermedad meningocócica en Paraguay, 1996-2015
. Revista Panamericana de Salud Pública 43, pages 1-8.
Crossref
Crossref
Terry Nolan, Maria Elena Santolaya, Ferdinandus de Looze, Helen Marshall, Peter Richmond, Sam Henein, Paul Rheault, Ken Heaton, Kirsten P. Perrett, Hartley Garfield, Anil Gupta, Murdo Ferguson, Diego D'Agostino, Daniela Toneatto & Miguel O'Ryan. (2019) Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine. Vaccine 37:9, pages 1209-1218.
Crossref
Crossref
Lidia C. Serra, Laura J. York, Paul Balmer & Chris Webber. (2018) Meningococcal Group A, C, W, and Y Tetanus Toxoid Conjugate Vaccine: A Review of Clinical Data in Adolescents. Journal of Adolescent Health 63:3, pages 269-279.
Crossref
Crossref
Meagan E. Peterson, Rebecca Mile, You Li, Harish Nair & Moe H. Kyaw. (2018) Meningococcal carriage in high-risk settings: A systematic review. International Journal of Infectious Diseases 73, pages 109-117.
Crossref
Crossref
Patrizio Pezzotti, Alessandro Miglietta, Arianna Neri, Cecilia Fazio, Paola Vacca, Fabio Voller, Giovanni Rezza & Paola Stefanelli. (2018) Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy. Vaccine 36:29, pages 4222-4227.
Crossref
Crossref
Luis Rivera, Tino F. Schwarz, Kyung-Hyo Kim, Yun-Kyung Kim, Ulrich Behre, Sung-Ho Cha, Dae Sun Jo, Jacob Lee, Jin-Soo Lee, Brigitte Cheuvart, Archana Jastorff & Marie Van der Wielen. (2018) Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study. Vaccine 36:31, pages 4750-4758.
Crossref
Crossref
Paul Balmer & Laura J. York. (2018) Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control. Therapeutic Advances in Vaccines and Immunotherapy 6:3, pages 49-60.
Crossref
Crossref
Miguel Delgado Rodríguez & Ángela Domínguez García. (2018) Pros y contras de la vacunación frente a la enfermedad por meningococo B. Medicina Clínica 150:3, pages 109-113.
Crossref
Crossref
Miguel Delgado Rodríguez & Ángela Domínguez García. (2018) Pros and cons of vaccination against disease caused by serogroup B meningococcal disease. Medicina Clínica (English Edition) 150:3, pages 109-113.
Crossref
Crossref
Patricia Anne O’Malley. (2018) Meningococcal Disease. Clinical Nurse Specialist 32:1, pages 15-18.
Crossref
Crossref
Ana Lucia Andrade, Ruth Minamisava, Lisia Moura Tomich, Ana Paula Lemos, Maria Cecilia Gorla, Maria Cristina de Cunto Brandileone, Carla Madga S. Domingues, Camile de Moraes, Gabriela Policena, Ana Luiza Bierrenbach, Elier B. Cristo & Cristiane Wanderley Cardoso. (2017) Impact of meningococcal C conjugate vaccination four years after introduction of routine childhood immunization in Brazil. Vaccine 35:16, pages 2025-2033.
Crossref
Crossref
D.P.J. Turner, N.J. Oldfield & C.D. Bayliss. (2017) University vaccine campaign increases meningococcal ACWY vaccine coverage. Public Health 145, pages 1-3.
Crossref
Crossref
M. L. A. GONZALES, V. BIANCO & A. VYSE. (2016) Meningococcal carriage in children and young adults in the Philippines: a single group, cross-sectional study. Epidemiology and Infection 145:1, pages 126-132.
Crossref
Crossref